Ancillary study for the "phase III Study of adjuvant chemotherapy for the patients resected pathological stage I (T1>2cm) non-small cell lung cancer": Evaluation of long-term prognosis after resection for early-stage non-small cell lung cancer (JCOG0707A1)
Not Applicable
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000048902
- Lead Sponsor
- Japan Clinical Oncology Group (JCOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 963
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method Recurrence-free survival, site of recurrence, cumulative incidence of secondary cancer, cumulative incidence of death from primary lung cancer, cumulative incidence of all causes of deaths (deaths from cancers and deaths from non-cancer causes)